Finding the tumor copycat: Therapy fails, patients don’t
The DOI matches its Crossref record; 12 of the 13 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Besides, animal models typically fail to provide a precise recapitulation of human physiology [74,100,101].”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [101]
Citations
Cites
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
Kobayashi, S., Boggon, T. J., Dayaram, T., Jänne, P. A., Kocher, O., Meyerson, M., Johnson, B. E., Eck, M. J., Tenen, D. G., & Halmos, B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044238 · Cited by 3,964
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
Heinrich, M. C., Corless, C. L., Demetri, G. D., Blanke, C. D., von Mehren, M., Joensuu, H., McGreevey, L. S., Chen, C.-J., Van den Abbeele, A. D., Druker, B. J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.190 · Cited by 2,299
Cunningham, D., Atkin, W., Lenz, H.-J., Lynch, H. T., Minsky, B., Nordlinger, B., & Starling, N. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60353-4 · Cited by 1,351
Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
Tol, J., Koopman, M., Cats, A., Rodenburg, C. J., Creemers, G. J. M., Schrama, J. G., Erdkamp, F. L. G., Vos, A. H., van Groeningen, C. J., Sinnige, H. A. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808268 · Cited by 1,341
AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
Talmadge, J. E., & Fidler, I. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1040 · Cited by 1,169
Self-citationBlanke, C. D., Rankin, C., Demetri, G. D., Ryan, C. W., von Mehren, M., Benjamin, R. S., Raymond, A. K., Bramwell, V. H. C., Baker, L. H., Maki, R. G., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.4452 · Cited by 1,073
Hecht, J. R., Mitchell, E., Chidiac, T., Scroggin, C., Hagenstad, C., Spigel, D., Marshall, J., Cohn, A., McCollum, D., Stella, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.8135 · Cited by 850
Saltz, L. B., Lenz, H.-J., Kindler, H. L., Hochster, H. S., Wadler, S., Hoff, P. M., Kemeny, N. E., Hollywood, E. M., Gonen, M., Quinones, M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.0949 · Cited by 425
Cited by
Langley, R. R., & Fidler, I. J. (2011) · International Journal of Cancer · doi:10.1002/ijc.26031 · Cited by 958
Self-citationPhenotypic screening in cancer drug discovery — past, present and future
Moffat, J. G., Rudolph, J., & Bailey, D. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4366 · Cited by 507
Halama, N., Zoernig, I., Berthel, A., Kahlert, C., Klupp, F., Suarez-Carmona, M., Suetterlin, T., Brand, K., Krauss, J., Lasitschka, F., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.005 · Cited by 495
Patient-derived xenograft (PDX) models, applications and challenges in cancer research
Abdolahi, S., Ghazvinian, Z., Muhammadnejad, S., Saleh, M., Asadzadeh Aghdaei, H., & Baghaei, K. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03405-8 · Cited by 326
Patient-derived xenograft models of breast cancer and their predictive power
Whittle, J. R., Lewis, M. T., Lindeman, G. J., & Visvader, J. E. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0523-1 · Cited by 282
Patient-derived xenograft (PDX) models in basic and translational breast cancer research
Dobrolecki, L. E., Airhart, S. D., Alferez, D. G., Aparicio, S., Behbod, F., Bentires-Alj, M., Brisken, C., Bult, C. J., Cai, S., Clarke, R. B., et al. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9653-x · Cited by 267
Goldman, A., Majumder, B., Dhawan, A., Ravi, S., Goldman, D., Kohandel, M., Majumder, P. K., & Sengupta, S. (2015) · Nature Communications · doi:10.1038/ncomms7139 · Cited by 260
Mast cells, angiogenesis, and tumour growth
Ribatti, D., & Crivellato, E. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.11.010 · Cited by 231
Only humans have human placentas: molecular differences between mice and humans
Schmidt, A., Morales-Prieto, D. M., Pastuschek, J., Fröhlich, K., & Markert, U. R. (2015) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2015.03.001 · Cited by 223
Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin
Delgado-Bellido, D., Serrano-Saenz, S., Fernández-Cortés, M., & Oliver, F. J. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0631-x · Cited by 214
Systematic reviews of animal models: methodology versus epistemology
Greek, R., & Menache, A. (2013) · International Journal of Medical Sciences · doi:10.7150/ijms.5529 · Cited by 207
The challenge of targeting metastasis
Fidler, I. J., & Kripke, M. L. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9586-9 · Cited by 185
Self-citationTrujillo-de Santiago, G., Flores-Garza, B. G., Tavares-Negrete, J. A., Lara-Mayorga, I. M., González-Gamboa, I., Zhang, Y. S., Rojas-Martínez, A., Ortiz-López, R., & Álvarez, M. M. (2019) · Materials · doi:10.3390/ma12182945 · Cited by 184
Sanmamed, M. F., Rodriguez, I., Schalper, K. A., Oñate, C., Azpilikueta, A., Rodriguez-Ruiz, M. E., Morales-Kastresana, A., Labiano, S., Pérez-Gracia, J. L., Martín-Algarra, S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3510 · Cited by 170
The Promise of Patient-Derived Xenografts: The Best Laid Plans of Mice and Men
Kopetz, S., Lemos, R., & Powis, G. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2408 · Cited by 176
Ehmsen, S., Pedersen, M. H., Wang, G., Terp, M. G., Arslanagic, A., Hood, B. L., Conrads, T. P., Leth-Larsen, R., & Ditzel, H. J. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.104 · Cited by 173
The Impact of the Immune System on Tumor: Angiogenesis and Vascular Remodeling
Stockmann, C., Schadendorf, D., Klose, R., & Helfrich, I. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00069 · Cited by 163
Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment
Garralda, E., Paz, K., Lopez-Casas, P. P., Jones, S., Katz, A. M., Kann, L. M., López‐Ríos, F., Sarno, F., Al‐Shahrour, F., Vasquez, D., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3047 · Cited by 159
Animal models of asthma: value, limitations and opportunities for alternative approaches
Holmes, A. M., Solari, R. C. E., & Holgate, S. T. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.05.014 · Cited by 157
Butler, D. E., Marlein, C. R., Walker, H. F., Frame, F. M., Mann, V. M., Simms, M. S., Davies, B. R., Collins, A. T., & Maitland, N. J. (2017) · Oncotarget · doi:10.18632/oncotarget.18082 · Cited by 143
Cancer stromal targeting (CAST) therapy
Matsumura, Y. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.010 · Cited by 113
Advancements in 3D Cell Culture Systems for Personalizing Anti-Cancer Therapies
Law, A. M. K., de la Fuente, L. R., Grundy, T. J., Fang, G., Valdés‐Mora, F., & Gallego‐Ortega, D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.782766 · Cited by 119
Fan, F., Samuel, S., Gaur, P., Lu, J., Dallas, N. A., Xia, L., Bose, D., Ramachandran, V, & Ellis, L. M. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.81 · Cited by 102
Self-citationMattie, M., Christensen, A., Chang, M. S., Yeh, W., Said, S., Shostak, Y., Capo, L., Verlinsky, A., An, Z., Joseph, I., et al. (2013) · Neoplasia · doi:10.1593/neo.13922 · Cited by 100
Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma.
Bassiri, H., Benavides, A. D., Haber, M., Gilmour, S. K., Norris, M. D., & Hogarty, M. D. (2015) · PubMed · doi:10.3978/j.issn.2224-4336.2015.04.06 · Cited by 96
Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression
Evageliou, N. F., Haber, M., Vu, A. T., Laetsch, T. W., Murray, J. E., Gamble, L. D., Cheng, N. C., Liu, K., Reese, M., Corrigan, K. A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2539 · Cited by 93
Tumor suppressor p53: from engaging DNA to target gene regulation
Sammons, M. A., Nguyen, T.-A. T., McDade, S. S., & Fischer, M. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa666 · Cited by 77
Collins, A. T., & Lang, S. (2018) · PeerJ · doi:10.7717/peerj.5981 · Cited by 76
New concept of cytotoxic immunoconjugate therapy targeting cancer‐induced fibrin clots
Yasunaga, M., Manabe, S., & Matsumura, Y. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01954.x · Cited by 76
T Lymphocytes Restrain Spontaneous Metastases in Permanent Dormancy
Romero, I., Garrido, C., Algarra, I., Collado, A., Garrido, F., & Garcia-Lora, A. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2084 · Cited by 76
Vascular channels formed by subpopulations of PECAM1+ melanoma cells
Dunleavey, J. M., Xiao, L., Thompson, J., Kim, M., Shields, J. M., Shelton, S. E., Irvin, D., Brings, V. E., Ollila, D. W., Brekken, R. A., et al. (2014) · Nature Communications · doi:10.1038/ncomms6200 · Cited by 74
Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue
Monsma, D. J., Monks, N. R., Cherba, D., Dylewski, D., Eugster, E., Jahn, H., Srikanth, S., Scott, S. B., Richardson, P. J., Everts, R. E., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-125 · Cited by 67
Klinghammer, K. F., Raguse, J. D., Plath, T., Albers, A. E., Joehrens, K., Zakarneh, A., Brzezicha, B., Wulf‐Goldenberg, A., Keilholz, U., Hoffmann, J., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29344 · Cited by 68
From Bench to Bedside: Lessons Learned in Translating Preclinical Studies in Cancer Drug Development
Lieu, C. H., Tan, A.-C., Leong, S., Diamond, J. R., & Eckhardt, S. G. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt209 · Cited by 61
Zhao, B., Wu, M., Hu, Z., Ma, Y., Qi, W., Zhang, Y., Li, Y., Yu, M., Wang, H., & Mo, W. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0167-1 · Cited by 62
VE-cadherin promotes vasculogenic mimicry by modulating kaiso-dependent gene expression
Delgado‐Bellido, D., Fernández‐Cortés, M., Rodríguez, M. I., Serrano, S., Carracedo, A., García-Díaz, Á., & Oliver, F. J. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0125-4 · Cited by 54
Sargenti, A., Musmeci, F., Bacchi, F., Delprete, C., Cristaldi, D. A., Cannas, F., Bonetti, S., Pasqua, S., Gazzola, D., Costa, D., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.564887 · Cited by 49
The methylation landscape of tumour metastasis
Cock-Rada, A. M., & Weitzman, J. B. (2012) · Biology of the Cell · doi:10.1111/boc.201200029 · Cited by 50
New concepts in breast cancer genomics and genetics
Gonçalves, R., Warner, W. A., Luo, J. R., & Ellis, M. J. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0460-4 · Cited by 47
Varesano, S., Zocchi, M. R., & Poggi, A. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00998 · Cited by 45
Cavaco, A. C. M., Rezaei, M., Niland, S., & Eble, J. A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112355 · Cited by 43
Mascolo, D. D., Varesano, S., Benelli, R., Mollica, H., Salis, A., Zocchi, M. R., Decuzzi, P., & Poggi, A. D. (2019) · Cancers · doi:10.3390/cancers12010104 · Cited by 40
dos Reis, E. M., Berti, F. V., Colla, G., & Porto, L. M. (2017) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.34055 · Cited by 36
Anti-angiogenic drug discovery: lessons from the past and thoughts for the future
Wu, J. M., & Staton, C. A. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.695774 · Cited by 37
The History and Implications of Testing Thalidomide on Animals
Greek, R., Shanks, N., & Rice, M. J. (2011) · The Journal of Philosophy Science & Law · doi:10.5840/jpsl20111133 · Cited by 38
Bielen, A. B., Box, G., Perryman, L., Bjerke, L. M., Popov, S., Jamin, Y., Jury, A., Valenti, M. R., Brandon, A. D. H., Martins, V., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105034109 · Cited by 35
Gioeli, D., Snow, C. J., Simmers, M. B., Hoang, S. A., Figler, R. A., Allende, J. A., Roller, D. G., Parsons, J. T., Wulfkuhle, J. D., Petricoin, E. F., et al. (2019) · Lab on a Chip · doi:10.1039/c8lc00755a · Cited by 31
Immunotherapy eradicates metastases with reversible defects in MHC class I expression
Garrido, C., Romero, I., Berruguilla, E., Cancela, B., Algarra, I., Collado, A., Garcia-Lora, A. M., & Garrido, F. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1027-1 · Cited by 35
Newell, M., Goruk, S., Mazurak, V. C., Postovit, L.-M. M., & Field, C. J. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05331-8 · Cited by 34
Benelli, R., Costa, D., Salvini, L., Tardito, S., Tosetti, F., Villa, F., Zocchi, M. R., & Poggi, A. D. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005660 · Cited by 36
Cancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique?
Wagner, S. C., Ichim, T. E., Ma, H., Szymanski, J., Perez, J. A., Lopez, J., Bogin, V., Patel, A. N., Marincola, F. M., & Kesari, S. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0688-5 · Cited by 35
Taurozzi, A. J., Beekharry, R., Wantoch, M., Labarthe, M., Walker, H. F., Seed, R., Simms, M. S., Rodrigues, G., Bradford, J. R., van der Horst, G., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188228 · Cited by 29
Singla, A. K., Downey, C. M., Bebb, G. D., & Jirik, F. R. (2015) · Oncoscience · doi:10.18632/oncoscience.117 · Cited by 29
The roles of patient‐derived xenograft models and artificial intelligence toward precision medicine
Babu, J. V., ArulJothi, K. N., Mythili, V. M. R., Singh, S. K., Prasher, P., Gupta, G., Dua, K., Rakshith, H. S., Kaliappan, K., & Anand, K. (2024) · MedComm · doi:10.1002/mco2.745 · Cited by 32
Tumor Heterogeneity and Personalized Cancer Medicine: Are we Being Outnumbered?
Cirkel, G. A., Hooijdonk, C. G. G., Koudijs, M. J., Willems, S. M., & Voest, E. E. (2014) · Future Oncology · doi:10.2217/fon.13.214 · Cited by 33
Yeo, C., Lee, H., & Lee, E. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.02.043 · Cited by 28
VE-Cadherin in Cancer-Associated Angiogenesis: A Deceptive Strategy of Blood Vessel Formation
Delgado‐Bellido, D., Oliver, F. J., Padilla, M. V. V., Lobo-Selma, L., Chacón-Barrado, A., Díaz‐Martín, J., & de Álava, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119343 · Cited by 30
Epithelial cancers in the post-genomic era: should we reconsider our lifestyle?
Holly, J. M. P., Zeng, L., & Perks, C. M. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9445-5 · Cited by 31
Ohman, K. A., Hashim, Y. M., Vangveravong, S., Nywening, T. M., Cullinan, D. R., Goedegebuure, S. P., Liu, J., Tine, B. A. V., Tiriac, H., Tuveson, D. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9551 · Cited by 28
Melanoma genotypes and phenotypes get personal
Pimiento, J. M., Larkin, E. M., Smalley, K. S. M., Wiersma, G., Monks, N. R., Smalley, I., Peterson, C. A., & Nickoloff, B. J. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.84 · Cited by 26
A historical perspective of pancreatic cancer mouse models
Colvin, E. K., & Scarlett, C. J. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.03.025 · Cited by 28
Monsma, D. J., Cherba, D., Richardson, P. J., Vance, S. M., Rangarajan, S. V., Dylewski, D., Eugster, E., Scott, S. B., Beuschel, N. L., Davidson, P. J., et al. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25039 · Cited by 24
Sp1 Plays a Key Role in Vasculogenic Mimicry of Human Prostate Cancer Cells
Han, D.-S., & Lee, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031321 · Cited by 23
Pece, R., Tavella, S., Costa, D., Varesano, S., Camodeca, C., Cuffaro, D., Nuti, E., Rossello, A., Alfano, M., D’Arrigo, C., et al. (2021) · Haematologica · doi:10.3324/haematol.2021.278469 · Cited by 23
Han, D.-S., Lee, H., & Lee, E. (2022) · Scientific Reports · doi:10.1038/s41598-022-24414-z · Cited by 23
“Lassie,” “Toto,” and Fellow Pet Dogs: Poised to Lead the Way for Advances in Cancer Prevention
Knapp, D. W., Dhawan, D., & Ostrander, E. A. (2015) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2015.35.e667 · Cited by 21
Li, M., Yue, G. G., Luo, L., Tsui, S. K., Fung, K., Ng, S. S. M., & Lau, C. B. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.574827 · Cited by 20
Chatterjee, K., Atay, N., Abler, D., Bhargava, S., Sahoo, P., Rockne, R. C., & Munson, J. M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020212 · Cited by 20
A multi-site feasibility study for personalized medicine in canines with Osteosarcoma
Monks, N. R., Cherba, D., Kamerling, S. G., Simpson, H., Rusk, A. W., Carter, D., Eugster, E., Mooney, M. R., Sigler, R. E., Steensma, M. R., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-158 · Cited by 15
Rice, M. J. (2011) · Philosophy Ethics and Humanities in Medicine · doi:10.1186/1747-5341-6-12 · Cited by 16
Evaluation of drug-targetable genes by defining modes of abnormality in gene expression
Park, J., Lee, J., & Choi, C. (2015) · Scientific Reports · doi:10.1038/srep13576 · Cited by 14
A Review of the Institute of Medicine’s Analysis of using Chimpanzees in Biomedical Research
Jones, R. C., & Greek, R. (2013) · Science and Engineering Ethics · doi:10.1007/s11948-013-9442-7 · Cited by 14
Schütte, U., Bisht, S., Brossart, P., & Feldmann, G. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.534453 · Cited by 14
Falvo, P., Gruener, S., Orecchioni, S., Pisati, F., Talarico, G., Mitola, G., Lombardi, D., Bravetti, G., Winkler, J., Barozzi, I., et al. (2025) · Cell Death and Differentiation · doi:10.1038/s41418-025-01447-1 · Cited by 14
Novo, S. M., Wedge, S. R., & Stark, L. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-12222-9 · Cited by 12
The Development of Deep Brain Stimulation for Movement Disorders
Greek, R. (2012) · Journal of Clinical Research & Bioethics · doi:10.4172/2155-9627.1000137 · Cited by 10
Kamitani, N., Nakamae, I., Yoneda‐Kato, N., Kato, J., & Sho, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-26863-y · Cited by 9
Words matter: Restoring respect and dignity when referring to individuals with cancer
Ellis, L. M., Blanke, C. D., & Kohn, E. C. (2017) · Cancer · doi:10.1002/cncr.30625 · Cited by 9
Self-citationIn vitro models: Can they unravel the complexities of cancer cell metastasis?
Pafitanis, S., Zacharia, L. C., Stylianou, A., & Gkretsi, V. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189293 · Cited by 9
Lee, H. W., Lee, K., Kim, D. G., Yang, H., & Nam, D. (2016) · PubMed · doi:10.14670/hh-11-695 · Cited by 8
Patient-Derived Xenograft Tumor Models: Overview and Relevance to IR
Sheth, R. A., Perkons, N. R., Dondossola, E., Subudhi, S. K., Gade, T. P. F., & Tam, A. L. (2018) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2018.01.782 · Cited by 8
Metastatic disease: A drug discovery perspective
Lehembre, F., & Regenass, U. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.03.005 · Cited by 9
Liu, H., Zhao, J., Yang, Y., Jin, G., Zhang, X., Wang, D., Xie, C. L., Liu, K., Chen, X., Li, X., et al. (2018) · Oncology Reports · doi:10.3892/or.2018.6653 · Cited by 8
Zhao, A., Zhou, C., Li, J.-J., Wang, Z., Zhu, H., Shen, S., Shao, Q., Gong, Q., Hu, L., & Chen, X. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.09.005 · Cited by 8
A novel humanized immune stroma PDX cancer model for therapeutic studies
Yang, D., Beddows, I., Tang, H., Bai, S., Cascio, S., McGonigal, S. C., Johnson, B. K., Powers, J. J., Acharya, R., Bao, R., et al. (2026) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-026-04349-4 · Cited by 8
Plowright, A. T., & Drowley, L. (2017) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2017.07.001 · Cited by 11
Shenoy, G. N., Greene, C., Bhatta, M., Baroja, M. L., Loyall, J. L., Balu‐Iyer, S. V., Kelleher, R. J., Carreno, B. M., Linette, G. P., Shultz, L. D., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1246 · Cited by 6
Evolution of Tumor Model: From Animal Model of Tumor to Tumor Model in Animal
Dey, N., Sun, Y., Leyland-Jones, B., & De, P. K. R. (2013) · Journal of Cancer Therapy · doi:10.4236/jct.2013.49168 · Cited by 9
Cutrera, J. J., Johnson, B., Ellis, L. M., & Li, S. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.10.022 · Cited by 6
Self-citationBurrell, J. S., Walker‐Samuel, S., Boult, J. K. R., Baker, L. C. J., Jamin, Y., Halliday, J., Waterton, J. C., & Robinson, S. P. (2016) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0000000000000102 · Cited by 7
Jang, J., Rath, O., Schüler, J. B., Sung, H. H., Jeon, H. G., Jeong, B. C., Seo, S. I., Jeon, S. S., Lee, H. M., Choi, H.-Y., et al. (2017) · Translational Oncology · doi:10.1016/j.tranon.2017.01.016 · Cited by 5
Bredberg, A. C. A., & Lavasani, S. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.06.030 · Cited by 2
Hirst, T. C., Wilson, E., Browne, D., & Sena, E. S. (2024) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdae193 · Cited by 3
Patient-Derived Xenografts From Lung Cancer and Their Potential Applications
Wang, L., Zhang, R., & Fang, B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804010-2.00020-5 · Cited by 1
Matsumura, Y., Yasunaga, M., & Manabe, S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7876-8_6 · Cited by 1
Mouse Models of Breast Cancer: Deceptions that Reveal the Truth
Couto, J. P., & Bentires‐Alj, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-48848-6_6 · Cited by 1
Methodologies Applied to Establish Cell Cultures in Prostate Cancer
Collins, A. T. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7845-8_3 · Cited by 1
Rybinski, B., Hosgood, H. D., Wiener, S. L., & Weiser, D. A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.587377 · Cited by 1
Aptsiauri, N., Garcia-Lora, A. M., & Cabrera, T. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6543-0_3
Mice and Men The Promise of Patient-Derived Xenografts: The Best Laid Plans of
Kopetz, S., Lemos, R., & Powis, G. (2012)
Metadata
- Authors
- Ellis, L. M., & Fidler, I. J.
- Corresponding author
- Ellis, Lee M
- Fidler, Isaiah J
- ORCID
- Ellis, Lee M
- Venue
- Nature Medicine
- Published
- 2010-09
- Volume
- 16
- Issue
- 9
- Pages
- 974-975
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2012235549
- Cited by
- 109
- References
- 13
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 4 · 2019: 6 · 2018: 8 · 2017: 13 · 2016: 6 · 2015: 10 · 2014: 10 · 2013: 11 · 2012: 9
- FWCI
- 4.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Veterinary › Small Animals › Veterinary Oncology Research
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Keywords
- metastatic cancer, mouse tumor model, translational research, treatment resistance, pancreatic tumors, drug testing, tumor growth, clinical trial failure
- MeSH terms
- Animals, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Cell Division, Clinical Trials as Topic, Disease Models, Animal, Genetic Engineering, Humans, Mutation, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms, Treatment Failure, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.